CSTL
Price
$33.19
Change
-$1.18 (-3.43%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.05B
14 days until earnings call
Intraday BUY SELL Signals
QTI
Price
$2.33
Change
+$0.02 (+0.87%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
33.81M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSTL vs QTI

CSTL vs QTI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSTL vs. QTI commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a StrongBuy and QTI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CSTL with price predictions
Oct 21, 2026

Momentum Indicator for CSTL turns positive, indicating new upward trend

CSTL saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 80 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 54 cases where CSTL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

CSTL moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 228 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

CSTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 198 of 227 cases where CSTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Bearish Trend Analysis

The 10-day RSI Indicator for CSTL moved out of overbought territory on September 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 28 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Moving Average Convergence Divergence Histogram (MACD) for CSTL turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 30 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (64.450). P/E Ratio (-53.703) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for QTI with price predictions
Oct 21, 2026

QTI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 25, 2026

QTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 16 of 21 cases where QTI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where QTI's RSI Indicator exited the oversold zone, 11 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTI advanced for three days, in 121 of 167 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QTI as a result. In 49 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.

The Moving Average Convergence Divergence Histogram (MACD) for QTI turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 23 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for QTI entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.054) is normal, around the industry mean (2.923). P/E Ratio (-1.662) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.267) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. QTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CSTL: Fundamental Ratings
CSTL
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSTLQTI
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CSTL: $34.37 vs. QTI: $2.31)
Brand notoriety: CSTL and QTI are both not notable
CSTL represents the Medical Specialties, while QTI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CSTL: 99% vs. QTI: 39%
Market capitalization -- CSTL: $1.01B vs. QTI: $34.47M
CSTL [@Medical Specialties] is valued at $1.01B. QTI’s [@Medical/Nursing Services] market capitalization is $34.47M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 1 FA rating(s) are green while QTI’s FA Score has 1 green FA rating(s).

  • CSTL’s FA Score: 1 green, 4 red.
  • QTI’s FA Score: 1 green, 4 red.
According to our system of comparison, CSTL is a better buy in the long-term than QTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 6 TA indicator(s) are bullish while QTI’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 6 bullish, 4 bearish.
  • QTI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than QTI.

Price Growth

CSTL (@Medical Specialties) experienced а +3.81% price change this week, while QTI (@Medical/Nursing Services) price change was -4.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

CSTL is expected to report earnings on Nov 05, 2026.

QTI is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Medical Specialties (-3.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
CSTL
Daily Signal:
Gain/Loss:
QTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
+3.68%
TCMD - CSTL
50%
Loosely correlated
-1.02%
NEO - CSTL
47%
Loosely correlated
+2.53%
GH - CSTL
44%
Loosely correlated
+2.50%
ADPT - CSTL
44%
Loosely correlated
+3.73%
NTRA - CSTL
40%
Loosely correlated
+1.84%
More

QTI and

Correlation & Price change

A.I.dvisor tells us that QTI and CSTL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QTI and CSTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTI
1D Price
Change %
QTI100%
-0.86%
CSTL - QTI
29%
Poorly correlated
+3.68%
OSUR - QTI
24%
Poorly correlated
+3.07%
CTKB - QTI
22%
Poorly correlated
+3.00%
NUWE - QTI
22%
Poorly correlated
-5.08%
CLPT - QTI
21%
Poorly correlated
-2.12%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INFU14.05-0.18
-1.26%
InfuSystem Holdings
AFYA14.90-0.20
-1.32%
Afya Limited
RYTM88.62-1.58
-1.75%
Rhythm Pharmaceuticals
SYK297.60-6.80
-2.23%
Stryker Corp
KOSS3.47-0.09
-2.53%
Koss Corp